Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel GPR120 modulators divulged by Bristol-Myers Squibb

Oct. 27, 2014

The Walter Reed Army Institute discloses new agents for malaria

Oct. 27, 2014

Flatley Discovery designs a new series of CFTR agents for cystic fibrosis

Oct. 24, 2014

Novartis synthesizes new agents for bacterial infections

Oct. 24, 2014

New O-GlcNAcase inhibitors patented by Merck KGaA

Oct. 24, 2014

Bristol-Myers Squibb divulges new NS5B inhibitors for HCV infection

Oct. 24, 2014

Researchers at NewLink Genetics disclose new IDO and TDO inhibitors

Oct. 24, 2014

Bristol-Myers Squibb reports new FFAR4 modulators

Oct. 23, 2014

CHDI Foundation discloses novel HDAC4 inhibitors for Huntington's disease

Oct. 23, 2014

KU Leuven discloses new viral replication inhibitors for Flaviviridae infections

Oct. 23, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...